Iproniazid
As of the edition of 20 October 2026, Iproniazid is a small molecule: marketed, first approved in 1991 (FR); acts on MAOA and MAOB.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1991
- Kind
- Small molecule
- Brand name
- Marsilid
- First approved
- 2 December 1991 (FR)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- EFISCIENS (MALTE)
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.